Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enriched outside the brain (adipocytes) | 0.10 |
| chemistry Open Targets | a small-molecule pocket: choriogonadotropin alfa, gonadotropin, chorionic, lutropin alfa +2 | 0.60 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 1 Parkinson's papers of 912 | 0.91 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 9500
Sealed predictions
- LHCGR in dopamine neurons, braak+0.13 (p 0.740) → +0.26 (p 0.504)receipt 9506
Swarm cases
receipt 9506: LHCGR in dopamine neurons, braak
- power
- full sample +0.20 (p 0.429, n 18), 95% CI -0.30 to +0.61. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.27 (p 0.285, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.00 (p 0.990, n 18). could be the mix.
- skeptic
- leave-one-out range +0.11 to +0.35, sign flips 0; without severely affected donors +0.20 (p 0.429, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LHCGR in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts